Perspective Therapeutics, Inc.

CATX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001535289-26-000003
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Spoor Johan M. (CEO)

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Stock option (right to buy)

Action

Grant

Date

2026-03-02

Code

A

Net shares

+735,000.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

735,000.0

Filing's footnotes

1. The option grant was approved by the Issuer's Board of Directors on January 26, 2026, with a grant date of March 2, 2026 (the &quot;Grant Date&quot;), and represents the Reporting Person's annual equity award for 2026.

2. Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.